ENG, PWRM, TLF, MHLD - Market Report From DrStockPick.com.

Nov. 4, 2010 - PRLog -- Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."

"We are within striking distance of realizing an Alzheimer's clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions," added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

************************************************************

Maiden Holdings, Ltd.  reported third quarter 2010 net income of $18.5 million, up 23.6% from $15.0 million in the third quarter of 2009.

Earnings per diluted share of $0.26 increased 23.8% from $0.21 in the third quarter of 2009.

Operating earnings for the quarter totaled $18.1 million, or $0.26 per diluted share, compared with $16.5 million, or $0.23 per diluted share in the third quarter of 2009.

************************************************************

Tandy Leather Factory, Inc.  reported that sales for the month of October were $5.1 million, up 5% from $4.9 million in October 2009.

Year to date sales are up 8% to $47.8 million in the current year compared to $44.3 million last year.

************************************************************

ENGlobal , a leading provider of energy-related project delivery solutions, reported its financial results for the third quarter ended September 30, 2010.

ENG reported third quarter net loss of $5.2 million, or $(0.19) earnings per diluted share, for the quarter ended September 30, 2010, a decrease from a net loss of $0.1 million, or $0.00 for the quarter ended September 30, 2009.

ENG’s third quarter operating results include a pre-tax charge of $7.2 million related to uncollectable note receivable from a bankrupt client, South Louisiana Ethanol.


************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).